Bunge invests $550 million to build new soy protein facility
The facility will produce soy protein concentrates and textured soy protein concentrates.
Photo © iStockphoto.com
Bunge (St. Louis) is investing $550 million to build a new facility for soy protein concentrates (SPC) and textured soy protein concentrates (TSPC). The company expects construction to begin in Q1 2023 and to be completed in mid-2025.
The site neighbors Bunge’s existing soybean processing plant in Morristown, IN, and will help the company process an additional 4.5 million bushels of soybeans to meet demand for plant-based foods, processed meat, pet food, and feed.
The company’s press release states, “The new facility is expected to add significant scale, efficiencies, and non-GMO capability to the company’s existing U.S.-based conventional SPC and TSPC operation in Bellevue, OH. The company plans to contract with farmers to establish a traceable soybean sourcing program starting with the 2025 harvest.”
In addition, Bunge has invested another $10 million “to enhance its plant protein technical capabilities at the Creative Solutions Center near its St. Louis headquarters.” With this funding, the site will add a commercial pilot plant to develop alternative meat and dairy, processed meat, and beverage products.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
